In PD, several GLP-1RAs have demonstrated promising disease-modifying effects in phase II RCTs, and the results of phase III trials are anticipated
He will monitor your progress, help manage any side effects, and adjust your treatment plan as necessary to ensure you experience the full benefits of appetite suppression
Metabolic Lab Testing Comprehensive bloodwork every six months
Simultaneously, these agents suppress glucagon secretion, a hormone that raises blood sugar levels
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Conversely, if you are on injections but struggling with side effects, switching to drops might provide adequate results with better tolerability